| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rikuto Christopher Shinohara, Tomomi Oshima, Takafumi Otsubo, Keita Ariga, Tesshu Ono, Koya Muneoka, Hiroki Umezu, Nobuhiro Mikam. Successful utilization of clozapine for a patient with treatment-resistant schizophrenia after recurrent violent behavior. Neuropsychopharmacology reports. 2024-07-04. PMID:38961521. |
successful utilization of clozapine for a patient with treatment-resistant schizophrenia after recurrent violent behavior. |
2024-07-04 |
2024-07-10 |
Not clear |
| Júlio César Menezes Vieira, Edna Afonso Reis, Augusto Afonso Guerra, Helian Nunes de Oliveira, Cristina Mariano Rua. Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia. Frontiers in psychiatry. vol 15. 2024-07-04. PMID:38962057. |
comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the brazilian national health system in adults with schizophrenia. |
2024-07-04 |
2024-07-10 |
Not clear |
| Júlio César Menezes Vieira, Edna Afonso Reis, Augusto Afonso Guerra, Helian Nunes de Oliveira, Cristina Mariano Rua. Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia. Frontiers in psychiatry. vol 15. 2024-07-04. PMID:38962057. |
we aimed to assess the survival of patients with schizophrenia using clozapine compared with non-clozapine atypical antipsychotics provided by the brazilian national health system using real-world data. |
2024-07-04 |
2024-07-10 |
Not clear |
| Sandeep Grover, Arshia Sood, Subho Chakrabart. Use of Clozapine in persons with a history of seizures: A retrospective study. Asian journal of psychiatry. vol 98. 2024-07-02. PMID:38955034. |
seizures are considered to be one of the dreaded side effects of clozapine, and due to this, the use of clozapine is avoided in patients with treatment-resistant schizophrenia. |
2024-07-02 |
2024-07-06 |
Not clear |
| S Nath, S K Padhy, S Kumar. Ivabradine-induced delirium in a patient taking clozapine for treatment-resistant schizophrenia: a case report. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan. vol 34. issue 1. 2024-07-02. PMID:38955780. |
ivabradine-induced delirium in a patient taking clozapine for treatment-resistant schizophrenia: a case report. |
2024-07-02 |
2024-07-06 |
Not clear |
| Mishal Qubad, Gabriele Dupont, Martina Hahn, Simon S Martin, Valentina Puntmann, Eike Nagel, Andreas Reif, Robert A Bittne. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. CNS drugs. 2024-07-01. PMID:38951464. |
when, why and how to re-challenge clozapine in schizophrenia following myocarditis. |
2024-07-01 |
2024-07-04 |
Not clear |
| Mishal Qubad, Gabriele Dupont, Martina Hahn, Simon S Martin, Valentina Puntmann, Eike Nagel, Andreas Reif, Robert A Bittne. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. CNS drugs. 2024-07-01. PMID:38951464. |
clozapine-induced myocarditis (cim) is among the most important adverse events limiting the use of clozapine as the most effective treatment for schizophrenia. |
2024-07-01 |
2024-07-04 |
Not clear |
| Ali Alalawi, Enas Albalawi, Abdullah Aljohani, Abdullah Almutairi, Abdulraouf Alrehili, Areej Albalawi, Ahmed Aldhafir. Decoding Clozapine-Induced Agranulocytosis: Unraveling Interactions and Mitigation Strategies. Pharmacy (Basel, Switzerland). vol 12. issue 3. 2024-06-26. PMID:38921968. |
clozapine is an antipsychotic medication that has demonstrated substantial efficacy in remediating refractory schizophrenia and various other psychiatric disorders. |
2024-06-26 |
2024-06-29 |
Not clear |
| Anton Freibüchler, Roland Seifer. Analysis of clinical studies on clozapine from 2012-2022. Naunyn-Schmiedeberg's archives of pharmacology. 2024-06-25. PMID:38918233. |
clozapine has been considered the "gold standard" in the treatment of schizophrenia for many years. |
2024-06-25 |
2024-06-29 |
Not clear |
| Anton Freibüchler, Roland Seifer. Analysis of clinical studies on clozapine from 2012-2022. Naunyn-Schmiedeberg's archives of pharmacology. 2024-06-25. PMID:38918233. |
however, due to its numerous adverse reactions, clozapine is mainly used for treatment-resistant schizophrenia. |
2024-06-25 |
2024-06-29 |
Not clear |
| Anton Freibüchler, Roland Seifer. Analysis of clinical studies on clozapine from 2012-2022. Naunyn-Schmiedeberg's archives of pharmacology. 2024-06-25. PMID:38918233. |
no investigated drug was superior to clozapine for the treatment of schizophrenia. |
2024-06-25 |
2024-06-29 |
Not clear |
| Edgardo Torres-Carmona, Shinichiro Nakajima, Yusuke Iwata, Fumihiko Ueno, Cristiana Stefan, Jianmeng Song, Ali Abdolizadeh, Michel Teruki Koizumi, Yasaman Kambari, Aron Amaev, Sri Mahavir Agarwal, Wanna Mar, Vincenzo de Luca, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrer. Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study. Schizophrenia research. vol 270. 2024-06-23. PMID:38909486. |
clozapine treatment and astrocyte activity in treatment resistant schizophrenia: a proton magnetic resonance spectroscopy study. |
2024-06-23 |
2024-06-26 |
human |
| Edgardo Torres-Carmona, Shinichiro Nakajima, Yusuke Iwata, Fumihiko Ueno, Cristiana Stefan, Jianmeng Song, Ali Abdolizadeh, Michel Teruki Koizumi, Yasaman Kambari, Aron Amaev, Sri Mahavir Agarwal, Wanna Mar, Vincenzo de Luca, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrer. Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study. Schizophrenia research. vol 270. 2024-06-23. PMID:38909486. |
clozapine is the only antipsychotic approved for treating treatment-resistant schizophrenia (trs), characterized by persistent positive symptoms despite adequate antipsychotic treatment. |
2024-06-23 |
2024-06-26 |
human |
| Fumihiko Kawai, Satsuki Watanabe, Hirotaka Ebihara, Naoki Shimizu, Shiori Oshima, Hiroshi Okai, Yoshiko Murata, Hisatoshi Arai, Koji Matsu. Recurrent reactive hypoglycemia due to clozapine-induced glucose intolerance: A case report. PCN reports : psychiatry and clinical neurosciences. vol 2. issue 4. 2024-06-13. PMID:38868726. |
although diabetes is one of the most common side effects of clozapine, a medication for the treatment of schizophrenia, to the best of our knowledge no study exists on clozapine-induced glucose intolerance or hypoglycemia in patients with schizophrenia. |
2024-06-13 |
2024-06-15 |
Not clear |
| Yi Yin, Chen Lin, Lijing Wei, Jinghui Tong, Junchao Huang, Baopeng Tian, Shuping Tan, Zhiren Wang, Fude Yang, Yongsheng Tong, Song Chen, L Elliot Hong, Yunlong Ta. History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study. BMC psychiatry. vol 24. issue 1. 2024-06-13. PMID:38867174. |
history of suicidal behavior and clozapine prescribing among people with schizophrenia in china: a cohort study. |
2024-06-13 |
2024-06-15 |
Not clear |
| Yi Yin, Chen Lin, Lijing Wei, Jinghui Tong, Junchao Huang, Baopeng Tian, Shuping Tan, Zhiren Wang, Fude Yang, Yongsheng Tong, Song Chen, L Elliot Hong, Yunlong Ta. History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study. BMC psychiatry. vol 24. issue 1. 2024-06-13. PMID:38867174. |
clozapine is an off-label drug used in most countries to prevent suicide in individuals with schizophrenia. |
2024-06-13 |
2024-06-15 |
Not clear |
| Yi Yin, Chen Lin, Lijing Wei, Jinghui Tong, Junchao Huang, Baopeng Tian, Shuping Tan, Zhiren Wang, Fude Yang, Yongsheng Tong, Song Chen, L Elliot Hong, Yunlong Ta. History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study. BMC psychiatry. vol 24. issue 1. 2024-06-13. PMID:38867174. |
this study aimed to explore the association between a history of suicidal behavior and clozapine prescribing during eight weeks of hospitalization for individuals with early-stage schizophrenia. |
2024-06-13 |
2024-06-15 |
Not clear |
| Alyssa K Kuhn, Meina L Determan, Jessica A Wright, Eric Matey, Jonathan G Leun. The potential influence of estrogen-containing oral contraception on clozapine metabolism in a patient with known pharmacogenomic status. The mental health clinician. vol 14. issue 3. 2024-06-05. PMID:38835816. |
a 17-year-old, nonsmoking, white female with a history of schizophrenia was initiated on clozapine 12.5 mg at bedtime with a plan to increase by 25 mg every 4 days in the outpatient setting. |
2024-06-05 |
2024-06-07 |
Not clear |
| Orwa Albitar, Sabariah Noor Harun, Siti Maisharah Sheikh Ghadz. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics. CNS drugs. 2024-06-05. PMID:38836990. |
background and objectives: clozapine is the medication of choice for treatment-resistant schizophrenia. |
2024-06-05 |
2024-06-07 |
human |
| Edward Silva, Sophie Legge, Cecilia Casetta, Eromona Whiskey, Ebenezer Oloyede, Siobhan Ge. Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it's a CIN. BJPsych bulletin. 2024-06-03. PMID:38828731. |
clozapine remains the gold standard intervention for treatment-resistant schizophrenia; however, it remains underused, especially for some minority groups. |
2024-06-03 |
2024-06-05 |
Not clear |